FDA Investigator Lillian S Wu
Lillian S Wu has inspections in 2 countries as of 20 Oct 2023. Lillian S Wu has collaborated with a combined 783 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
11
Last Inspection Date:
20 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
India
Co-Investigator(s):
Alan P Kurtzberg,
Alicia M Mozzachio,
Andrew K Haack, PhD,
Andy B Lee,
Bryan L Mcguckin,
Carr Sharpe,
Caryn M Mcnab,
Crystal Monroy,
Debra I Love,
Diane Cvan Leeuwen,
Jeffrey P Raimondi,
Joel D Hustedt,
John A Gonzalez,
Juanita Banuelos,
Junho Pak,
Katherine Szestypalow,
Kelley,
Kellia N Hicks,
Kelvin X Sanders,
Kham Phommachanh,
Khoa Nathanv Tran,
Kristy A Zielny,
Langer,
Larry K Austin,
Liming Zhang,
Lisa Shin,
Marcus F Yambot,
Marvin D Jones,
Maxyne T Lam,
Michael A Charles,
Michael L Casner,
Nicholas Fragedakis,
Nicholas L Hunt,
Nicole E Knowlton,
Parul M Patel,
Patrick C Klotzbuecher,
Robert M Barbosa,
Roger F Zabinski,
Rowena S Nguyen,
Saied A Asbagh,
Stephanie A Slater, MS,
Susan M Jackson,
Theresa Kirkham (NMI),
Virgilio F Pacio, CSO,
Youkeun Kim,
Zachary A Bogorad
Lillian S Wu's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2023 | FDA 483 | Packaging On Demand, Inc. - Form 483, 2023-01-13 |
April, 2023 | FDA 483 Response | COLONIAL DAMES CO LTD - Form 483R, 2023-04-12 |
April, 2023 | FDA 483 | COLONIAL DAMES CO LTD - Form 483, 2023-04-12 |
September, 2022 | FDA 483 | Formology Lab Inc. - Form 483, 2022-09-19 |
November, 2022 | FDA 483 | Pharmedica USA, LLC - Form 483, 2022-11-07 |
August, 2023 | FDA 483 | CRONUS PHARMA SPECIALITIES INDIA PRIVATE LIMITED - Form 483, 2023-08-29 |
June, 2022 | FDA 483 | Airgas Usa, LLC - Form 483, 2022-06-07 |
December, 2023 | FDA 483 | Medsource Pharmaceuticals - Form 483, 2023-12-11 |
October, 2023 | FDA 483 | THE HAIN CELESTIAL GROUP INC - Form 483, 2023-10-20 |
March, 2024 | FDA 483 | Amphastar Pharmaceuticals, Inc. - Form 483, 2024-03-01 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more